Nuvinta Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.20 M
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 300.55%
- Profit Growth -173.91%
- Ebitda 144.10%
- Net Worth -15.54%
- Total Assets 105.17%
About Nuvinta Life Sciences
Nuvinta Life Sciences Private Limited (NLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 July 2020 (Four years and six months 20 days old ). Its registered office is in Adilabad, Telangana, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Mohammad Basiruddin and Syed Rasheed serve as directors at the Company.
Company Details
-
Location
Adilabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909TG2020PTC142052
-
Company No.
142052
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Jul 2020
-
Date of AGM
28 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Nuvinta Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohammad Basiruddin
|
Director | 22-Jul-2020 | Current |
|
Syed Rasheed
|
Director | 22-Jul-2020 | Current |
Financial Performance of Nuvinta Life Sciences.
Nuvinta Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 300.55% increase. The company also saw a substantial fall in profitability, with a 173.91% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nuvinta Life Sciences?
Unlock access to Nuvinta Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Sanko Biotech Private LimitedMohammad Basiruddin is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nuvinta Life Sciences?
Nuvinta Life Sciences has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nuvinta Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuvinta Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.